Company Filing History:
Years Active: 2024
Title: Paul Mudd: Innovator in Overactive Bladder Treatment
Introduction
Paul Mudd is a notable inventor based in Cary, NC (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of overactive bladder. His innovative approach has led to the development of a unique method for administering medication to patients in need.
Latest Patents
Paul Mudd holds a patent for the use of vibegron to treat overactive bladder. The patent details a method that involves orally administering an amount of vibegron ranging from about 60 mg to about 90 mg per day, with a preferred dosage of approximately 75 mg. This patent represents a significant advancement in the management of overactive bladder symptoms.
Career Highlights
Throughout his career, Paul Mudd has been associated with Urovant Sciences GmbH, a company dedicated to developing innovative treatments for urological conditions. His work has focused on improving patient outcomes through effective pharmaceutical solutions.
Collaborations
Paul Mudd collaborates with Stephen C Piscitelli, contributing to the advancement of research and development in the field of urology. Their combined expertise enhances the potential for innovative treatments.
Conclusion
Paul Mudd's contributions to the treatment of overactive bladder through his patent on vibegron exemplify his commitment to improving patient care. His work at Urovant Sciences GmbH and collaborations with fellow professionals highlight the importance of innovation in the pharmaceutical industry.